Watch the NEJM Quick Take of this trial.
Neisseria gonorrhoeae infections pose a public health challenge worldwide, and no vaccines are currently licensed. Observational studies suggest that the 4CMenB vaccine may reduce the risk of gonorrhea. New research findings are summarized in a short video.